Format
Sort by

Send to:

Choose Destination

Results: 5

Related Articles by Review for PubMed (Select 22205930)

1.

Safety and reactogenicity of canarypox ALVAC-HIV (vCP1521) and HIV-1 gp120 AIDSVAX B/E vaccination in an efficacy trial in Thailand.

Pitisuttithum P, Rerks-Ngarm S, Bussaratid V, Dhitavat J, Maekanantawat W, Pungpak S, Suntharasamai P, Vanijanonta S, Nitayapan S, Kaewkungwal J, Benenson M, Morgan P, O'Connell RJ, Berenberg J, Gurunathan S, Francis DP, Paris R, Chiu J, Stablein D, Michael NL, Excler JL, Robb ML, Kim JH.

PLoS One. 2011;6(12):e27837. doi: 10.1371/journal.pone.0027837. Epub 2011 Dec 21.

2.

Phase III HIV vaccine trial in Thailand: a step toward a protective vaccine for HIV.

Vaccari M, Poonam P, Franchini G.

Expert Rev Vaccines. 2010 Sep;9(9):997-1005. doi: 10.1586/erv.10.104. Review.

PMID:
20822342
3.

HIV vaccines in infants and children.

Lambert JS.

Paediatr Drugs. 2005;7(5):267-76. Review.

PMID:
16220994
4.

Human immunodeficiency virus vaccine trials.

O'Connell RJ, Kim JH, Corey L, Michael NL.

Cold Spring Harb Perspect Med. 2012 Dec 1;2(12):a007351. doi: 10.1101/cshperspect.a007351. Review.

5.

HIV vaccines: lessons learned and the way forward.

Kim JH, Rerks-Ngarm S, Excler JL, Michael NL.

Curr Opin HIV AIDS. 2010 Sep;5(5):428-34. doi: 10.1097/COH.0b013e32833d17ac. Review.

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk